Skip to main content

Correction to: Identification and validation of the high expression of pseudogene TCAM1P in cervical cancer via integrated bioinformatics analysis

The Original Article was published on 11 January 2022

Correction to: Cancer Cell International (2022) 22:17 https://doi.org/10.1186/s12935-021-02440-7

In this article [1], there was an error in naming the Table 4. In the paragraph, Results of "Correlation between TCAM1P and clinicopathological characteristics in patients with CC", the sentence "Result showed that TCAM1P expression is higher in patients with Lymph node metastasis than in non-metastasis while the difference was not statistically significant in the remaining groups (Table 1)’’. This should be Table 4. Also, in Fig. 4B, it is not “Hela” but “Caski”.

Table 4 and corrected Fig. 4 are given in this erratum.

Fig. 4
figure 4

TCAM1P promotes the proliferation of cervical cancer cells. A, B Cell proliferation abilities were detected by CCK-8 for treated Siha and Caski cells. C, D Cell proliferation abilities were detected by colony formation assays for treated Siha and Caski cells. The data are presented as the mean ± SD,  ***P < 0.001, ****P < 0.0001

Table 4 Analysis of the relationship between the expression of TCAM1P and the clinicopathological characteristics of cervical cancer patients based on the TCGA database

Reference

  1. Zhu Y, Ren C, Yang L, Zhang Z, Gong M, Chen K. Identification and validation of the high expression of pseudogene TCAM1P in cervical cancer via integrated bioinformatics analysis. Cancer Cell Int. 2022;22:17. https://doi.org/10.1186/s12935-021-02440-7.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chenchen Ren.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhu, Y., Ren, C., Yang, L. et al. Correction to: Identification and validation of the high expression of pseudogene TCAM1P in cervical cancer via integrated bioinformatics analysis. Cancer Cell Int 22, 77 (2022). https://doi.org/10.1186/s12935-022-02516-y

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12935-022-02516-y